Description

Streptocinaza (streptokinase) lyophilizate for solution for infusion 1 500 000 IU №1 vial

Ingredients

Streptokinase is the active ingredient in Streptocinaza. Each vial contains 1,500,000 IU of streptokinase in lyophilized form for reconstitution.

Dosage

The recommended dosage of Streptocinaza is determined by a healthcare professional based on the patient’s condition. It is typically administered intravenously over a specific period.

Indications

Streptocinaza is indicated for the treatment of acute myocardial infarction, pulmonary embolism, and deep vein thrombosis. It works by dissolving blood clots to restore blood flow.

Contraindications

Patients with a history of stroke, bleeding disorders, or recent surgery may have contraindications to using Streptocinaza. It is important to consult with a healthcare provider before starting treatment.

Directions

Streptocinaza should be administered by healthcare professionals in a clinical setting. The reconstituted solution is for intravenous use only and should not be administered by any other route.

Scientific Evidence

Streptocinaza, a thrombolytic agent, has been extensively studied for its efficacy in treating various thrombotic conditions. Research published in the Journal of the American Medical Association (JAMA) has shown that streptokinase is effective in improving outcomes in patients with acute myocardial infarction.

Additional Information

Streptocinaza works by activating plasminogen to form plasmin, which breaks down fibrin in blood clots. This pharmacological action helps restore blood flow in occluded vessels, reducing the risk of tissue damage. Clinical trials have demonstrated the benefits of streptokinase in improving patient survival rates and reducing complications associated with thrombotic events.

Streptocinaza has shown comparable effectiveness to other thrombolytic agents like alteplase but may have a different safety profile. It is essential for healthcare providers to weigh the benefits and risks when choosing a thrombolytic therapy for patients.